OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
78 hedge funds and large institutions have $257M invested in OncoMed Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
24% more call options, than puts
Call options by funds: $1.02M | Put options by funds: $819K
15% more funds holding
Funds holding: 68 → 78 (+10)
Holders
78
Holding in Top 10
2
Calls
$1.02M
Puts
$819K
Top Buyers
| 1 | +$2.15M | |
| 2 | +$2.1M | |
| 3 | +$1.57M | |
| 4 |
Mitsubishi UFJ Asset Management
Tokyo,
Japan
|
+$1.41M |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
+$1.26M |
Top Sellers
| 1 | -$3.42M | |
| 2 | -$2.4M | |
| 3 | -$2.34M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.67M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.42M |